申请人:John Wyeth & Brother Limited
公开号:US04291042A1
公开(公告)日:1981-09-22
Compounds of formula: ##STR1## and pharmaceutically acceptable acid addition or quaternary ammonium salts thereof wherein the piperidine ring is substituted in the 3 or 4 position; X represents .dbd.CH-- or .dbd.N--; Y represents --NR.sup.5 --, --O-- or --S-- wherein R.sup.5 is hydrogen or lower alkyl; A is lower alkylene or hydroxy lower alkylene, Z and Z.sup.1 independently represent ##STR2## Z may also represent --CH.sub.2 --, --(CH.sub.2).sub.2 --, --CHMe-- or --CMe.sub.2 --; R.sup.1, R.sup.2, R.sup.3 independently represent hydrogen, halogen, lower alkyl, lower alkoxy, nitro, amino, lower alkylamino, trifluoromethyl, lower-alkanoylamino, hydroxy or aryl lower alkoxy; or R.sup.1 and R.sup.2 when adjacent together with the carbons to which they are attached form a six membered carbocyclic ring; and R.sup.4 represents hydrogen or lower alkyl, are disclosed which possess psychotropic activity and are useful as anti-depressants.
本发明涉及一种化合物的配方:##STR1##以及其药学上可接受的酸加成物或季铵盐,其中哌啶环在3或4位置上被取代;X代表.dbd.CH--或.dbd.N--;Y代表--NR.sup.5--,--O--或--S--,其中R.sup.5为氢或低级烷基;A为低级烷基或羟基低级烷基,Z和Z.sup.1独立地代表##STR2##Z还可以代表--CH.sub.2--,--(CH.sub.2).sub.2--,--CHMe--或--CMe.sub.2--;R.sup.1,R.sup.2,R.sup.3独立地代表氢,卤素,低级烷基,低级烷氧基,硝基,氨基,低级烷基氨基,三氟甲基,低级烷酰胺基,羟基或芳基低级烷氧基;或当R.sup.1和R.sup.2与它们附着的碳形成一个六元环碳环时,它们相邻;R.sup.4代表氢或低级烷基。这些化合物具有精神活性,并可用作抗抑郁药物。